1 Study Coverage
1.1 NSAID API Product Introduction
1.2 Global NSAID API Outlook 2017 VS 2022 VS 2028
1.2.1 Global NSAID API Sales in US$ Million for the Year 2017-2028
1.2.2 Global NSAID API Sales in Volume for the Year 2017-2028
1.3 United States NSAID API Outlook 2017 VS 2022 VS 2028
1.3.1 United States NSAID API Sales in US$ Million for the Year 2017-2028
1.3.2 United States NSAID API Sales in Volume for the Year 2017-2028
1.4 NSAID API Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States NSAID API in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of NSAID API Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 NSAID API Market Dynamics
1.5.1 NSAID API Industry Trends
1.5.2 NSAID API Market Drivers
1.5.3 NSAID API Market Challenges
1.5.4 NSAID API Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 NSAID API Market Segment by Type
2.1.1 Paracetamol
2.1.2 Ibuprofen
2.1.3 Aspirin
2.1.4 Naproxen
2.1.5 Others
2.2 Global NSAID API Market Size by Type
2.2.1 Global NSAID API Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global NSAID API Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global NSAID API Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States NSAID API Market Size by Type
2.3.1 United States NSAID API Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States NSAID API Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States NSAID API Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 NSAID API Market Segment by Application
3.1.1 Captive Manufacturing
3.1.2 Contract Manufacturing
3.2 Global NSAID API Market Size by Application
3.2.1 Global NSAID API Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global NSAID API Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global NSAID API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States NSAID API Market Size by Application
3.3.1 United States NSAID API Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States NSAID API Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States NSAID API Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global NSAID API Competitor Landscape by Company
4.1 Global NSAID API Market Size by Company
4.1.1 Top Global NSAID API Manufacturers Ranked by Revenue (2021)
4.1.2 Global NSAID API Revenue by Manufacturer (2017-2022)
4.1.3 Global NSAID API Sales by Manufacturer (2017-2022)
4.1.4 Global NSAID API Price by Manufacturer (2017-2022)
4.2 Global NSAID API Concentration Ratio (CR)
4.2.1 NSAID API Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of NSAID API in 2021
4.2.3 Global NSAID API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global NSAID API Manufacturing Base Distribution, Product Type
4.3.1 Global NSAID API Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers NSAID API Product Type
4.3.3 Date of International Manufacturers Enter into NSAID API Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States NSAID API Market Size by Company
4.5.1 Top NSAID API Players in United States, Ranked by Revenue (2021)
4.5.2 United States NSAID API Revenue by Players (2020, 2021 & 2022)
4.5.3 United States NSAID API Sales by Players (2020, 2021 & 2022)
5 Global NSAID API Market Size by Region
5.1 Global NSAID API Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global NSAID API Market Size in Volume by Region (2017-2028)
5.2.1 Global NSAID API Sales in Volume by Region: 2017-2022
5.2.2 Global NSAID API Sales in Volume Forecast by Region (2023-2028)
5.3 Global NSAID API Market Size in Value by Region (2017-2028)
5.3.1 Global NSAID API Sales in Value by Region: 2017-2022
5.3.2 Global NSAID API Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America NSAID API Market Size YoY Growth 2017-2028
6.1.2 North America NSAID API Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific NSAID API Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific NSAID API Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe NSAID API Market Size YoY Growth 2017-2028
6.3.2 Europe NSAID API Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America NSAID API Market Size YoY Growth 2017-2028
6.4.2 Latin America NSAID API Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa NSAID API Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa NSAID API Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Novartis
7.1.1 Novartis Corporation Information
7.1.2 Novartis Description and Business Overview
7.1.3 Novartis NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Novartis NSAID API Products Offered
7.1.5 Novartis Recent Development
7.2 Pfizer
7.2.1 Pfizer Corporation Information
7.2.2 Pfizer Description and Business Overview
7.2.3 Pfizer NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Pfizer NSAID API Products Offered
7.2.5 Pfizer Recent Development
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporation Information
7.3.2 Boehringer Ingelheim Description and Business Overview
7.3.3 Boehringer Ingelheim NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Boehringer Ingelheim NSAID API Products Offered
7.3.5 Boehringer Ingelheim Recent Development
7.4 Teva Pharmaceutical
7.4.1 Teva Pharmaceutical Corporation Information
7.4.2 Teva Pharmaceutical Description and Business Overview
7.4.3 Teva Pharmaceutical NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Pharmaceutical NSAID API Products Offered
7.4.5 Teva Pharmaceutical Recent Development
7.5 BASF
7.5.1 BASF Corporation Information
7.5.2 BASF Description and Business Overview
7.5.3 BASF NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.5.4 BASF NSAID API Products Offered
7.5.5 BASF Recent Development
7.6 Hospira
7.6.1 Hospira Corporation Information
7.6.2 Hospira Description and Business Overview
7.6.3 Hospira NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Hospira NSAID API Products Offered
7.6.5 Hospira Recent Development
7.7 Lonza Group
7.7.1 Lonza Group Corporation Information
7.7.2 Lonza Group Description and Business Overview
7.7.3 Lonza Group NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Lonza Group NSAID API Products Offered
7.7.5 Lonza Group Recent Development
7.8 Mylan
7.8.1 Mylan Corporation Information
7.8.2 Mylan Description and Business Overview
7.8.3 Mylan NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Mylan NSAID API Products Offered
7.8.5 Mylan Recent Development
7.9 Aurobindo Pharma
7.9.1 Aurobindo Pharma Corporation Information
7.9.2 Aurobindo Pharma Description and Business Overview
7.9.3 Aurobindo Pharma NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Aurobindo Pharma NSAID API Products Offered
7.9.5 Aurobindo Pharma Recent Development
7.10 Cambrex
7.10.1 Cambrex Corporation Information
7.10.2 Cambrex Description and Business Overview
7.10.3 Cambrex NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Cambrex NSAID API Products Offered
7.10.5 Cambrex Recent Development
7.11 Dr. Reddy's Laboratories
7.11.1 Dr. Reddy's Laboratories Corporation Information
7.11.2 Dr. Reddy's Laboratories Description and Business Overview
7.11.3 Dr. Reddy's Laboratories NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Dr. Reddy's Laboratories NSAID API Products Offered
7.11.5 Dr. Reddy's Laboratories Recent Development
7.12 Actavis
7.12.1 Actavis Corporation Information
7.12.2 Actavis Description and Business Overview
7.12.3 Actavis NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Actavis Products Offered
7.12.5 Actavis Recent Development
7.13 Wuxi Apptec
7.13.1 Wuxi Apptec Corporation Information
7.13.2 Wuxi Apptec Description and Business Overview
7.13.3 Wuxi Apptec NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Wuxi Apptec Products Offered
7.13.5 Wuxi Apptec Recent Development
7.14 Zhejiang NHU
7.14.1 Zhejiang NHU Corporation Information
7.14.2 Zhejiang NHU Description and Business Overview
7.14.3 Zhejiang NHU NSAID API Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Zhejiang NHU Products Offered
7.14.5 Zhejiang NHU Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 NSAID API Industry Chain Analysis
8.2 NSAID API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 NSAID API Distributors
8.3 NSAID API Production Mode & Process
8.4 NSAID API Sales and Marketing
8.4.1 NSAID API Sales Channels
8.4.2 NSAID API Distributors
8.5 NSAID API Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. NSAID API CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. NSAID API Market Trends
Table 3. NSAID API Market Drivers
Table 4. NSAID API Market Challenges
Table 5. NSAID API Market Restraints
Table 6. Global NSAID API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States NSAID API Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global NSAID API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States NSAID API Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top NSAID API Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global NSAID API Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global NSAID API Revenue Share by Manufacturer, 2017-2022
Table 13. Global NSAID API Sales by Manufacturer, (K MT), 2017-2022
Table 14. Global NSAID API Sales Share by Manufacturer, 2017-2022
Table 15. Global NSAID API Price by Manufacturer (2017-2022) & (USD/MT)
Table 16. Global NSAID API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global NSAID API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in NSAID API as of 2021)
Table 18. Top Players of NSAID API in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers NSAID API Product Type
Table 20. Date of International Manufacturers Enter into NSAID API Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top NSAID API Players in United States Market, Ranking by Revenue (2021)
Table 23. United States NSAID API Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States NSAID API Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States NSAID API Sales by Players, (K MT), 2020, 2021 & 2022
Table 26. United States NSAID API Sales Share by Players, 2020, 2021 & 2022
Table 27. Global NSAID API Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global NSAID API Sales in Volume by Region (2017-2022) & (K MT)
Table 29. Global NSAID API Sales in Volume Forecast by Region (2023-2028) & (K MT)
Table 30. Global NSAID API Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global NSAID API Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America NSAID API Sales in Volume by Country (2017-2028) & (K MT)
Table 33. North America NSAID API Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific NSAID API Sales in Volume by Region (2017-2028) & (K MT)
Table 35. Asia Pacific NSAID API Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe NSAID API Sales in Volume by Country (2017-2028) & (K MT)
Table 37. Europe NSAID API Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America NSAID API Sales in Volume by Country (2017-2028) & (K MT)
Table 39. Latin Americaa NSAID API Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa NSAID API Sales in Volume by Country (2017-2028) & (K MT)
Table 41. Middle East and Africa NSAID API Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Novartis Corporation Information
Table 43. Novartis Description and Business Overview
Table 44. Novartis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 45. Novartis NSAID API Product
Table 46. Novartis Recent Development
Table 47. Pfizer Corporation Information
Table 48. Pfizer Description and Business Overview
Table 49. Pfizer NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 50. Pfizer Product
Table 51. Pfizer Recent Development
Table 52. Boehringer Ingelheim Corporation Information
Table 53. Boehringer Ingelheim Description and Business Overview
Table 54. Boehringer Ingelheim NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 55. Boehringer Ingelheim Product
Table 56. Boehringer Ingelheim Recent Development
Table 57. Teva Pharmaceutical Corporation Information
Table 58. Teva Pharmaceutical Description and Business Overview
Table 59. Teva Pharmaceutical NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 60. Teva Pharmaceutical Product
Table 61. Teva Pharmaceutical Recent Development
Table 62. BASF Corporation Information
Table 63. BASF Description and Business Overview
Table 64. BASF NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 65. BASF Product
Table 66. BASF Recent Development
Table 67. Hospira Corporation Information
Table 68. Hospira Description and Business Overview
Table 69. Hospira NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 70. Hospira Product
Table 71. Hospira Recent Development
Table 72. Lonza Group Corporation Information
Table 73. Lonza Group Description and Business Overview
Table 74. Lonza Group NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 75. Lonza Group Product
Table 76. Lonza Group Recent Development
Table 77. Mylan Corporation Information
Table 78. Mylan Description and Business Overview
Table 79. Mylan NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 80. Mylan Product
Table 81. Mylan Recent Development
Table 82. Aurobindo Pharma Corporation Information
Table 83. Aurobindo Pharma Description and Business Overview
Table 84. Aurobindo Pharma NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 85. Aurobindo Pharma Product
Table 86. Aurobindo Pharma Recent Development
Table 87. Cambrex Corporation Information
Table 88. Cambrex Description and Business Overview
Table 89. Cambrex NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 90. Cambrex Product
Table 91. Cambrex Recent Development
Table 92. Dr. Reddy's Laboratories Corporation Information
Table 93. Dr. Reddy's Laboratories Description and Business Overview
Table 94. Dr. Reddy's Laboratories NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 95. Dr. Reddy's Laboratories Product
Table 96. Dr. Reddy's Laboratories Recent Development
Table 97. Actavis Corporation Information
Table 98. Actavis Description and Business Overview
Table 99. Actavis NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 100. Actavis Product
Table 101. Actavis Recent Development
Table 102. Wuxi Apptec Corporation Information
Table 103. Wuxi Apptec Description and Business Overview
Table 104. Wuxi Apptec NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 105. Wuxi Apptec Product
Table 106. Wuxi Apptec Recent Development
Table 107. Zhejiang NHU Corporation Information
Table 108. Zhejiang NHU Description and Business Overview
Table 109. Zhejiang NHU NSAID API Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 110. Zhejiang NHU Product
Table 111. Zhejiang NHU Recent Development
Table 112. Key Raw Materials Lists
Table 113. Raw Materials Key Suppliers Lists
Table 114. NSAID API Customers List
Table 115. NSAID API Distributors List
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. NSAID API Product Picture
Figure 2. Global NSAID API Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global NSAID API Market Size 2017-2028 (US$ Million)
Figure 4. Global NSAID API Sales 2017-2028 (K MT)
Figure 5. United States NSAID API Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States NSAID API Market Size 2017-2028 (US$ Million)
Figure 7. United States NSAID API Sales 2017-2028 (K MT)
Figure 8. United States NSAID API Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States NSAID API Market Share in Global, in Volume (K MT) 2017-2028
Figure 10. NSAID API Report Years Considered
Figure 11. Product Picture of Paracetamol
Figure 12. Product Picture of Ibuprofen
Figure 13. Product Picture of Aspirin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Others
Figure 16. Global NSAID API Market Share by Type in 2022 & 2028
Figure 17. Global NSAID API Sales in Value by Type (2017-2028) & (US$ Million)
Figure 18. Global NSAID API Sales Market Share in Value by Type (2017-2028)
Figure 19. Global NSAID API Sales by Type (2017-2028) & (K MT)
Figure 20. Global NSAID API Sales Market Share in Volume by Type (2017-2028)
Figure 21. Global NSAID API Price by Type (2017-2028) & (USD/MT)
Figure 22. United States NSAID API Market Share by Type in 2022 & 2028
Figure 23. United States NSAID API Sales in Value by Type (2017-2028) & (US$ Million)
Figure 24. United States NSAID API Sales Market Share in Value by Type (2017-2028)
Figure 25. United States NSAID API Sales by Type (2017-2028) & (K MT)
Figure 26. United States NSAID API Sales Market Share in Volume by Type (2017-2028)
Figure 27. United States NSAID API Price by Type (2017-2028) & (USD/MT)
Figure 28. Product Picture of Captive Manufacturing
Figure 29. Product Picture of Contract Manufacturing
Figure 30. Global NSAID API Market Share by Application in 2022 & 2028
Figure 31. Global NSAID API Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global NSAID API Sales Market Share in Value by Application (2017-2028)
Figure 33. Global NSAID API Sales by Application (2017-2028) & (K MT)
Figure 34. Global NSAID API Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global NSAID API Price by Application (2017-2028) & (USD/MT)
Figure 36. United States NSAID API Market Share by Application in 2022 & 2028
Figure 37. United States NSAID API Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States NSAID API Sales Market Share in Value by Application (2017-2028)
Figure 39. United States NSAID API Sales by Application (2017-2028) & (K MT)
Figure 40. United States NSAID API Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States NSAID API Price by Application (2017-2028) & (USD/MT)
Figure 42. North America NSAID API Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 43. North America NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe NSAID API Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 47. Europe NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific NSAID API Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 54. Asia-Pacific NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America NSAID API Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 66. Latin America NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa NSAID API Sales in Volume Growth Rate 2017-2028 (K MT)
Figure 71. Middle East & Africa NSAID API Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. UAE NSAID API Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. NSAID API Value Chain
Figure 76. NSAID API Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Novartis Pfizer Boehringer Ingelheim Teva Pharmaceutical BASF Hospira Lonza Group Mylan Aurobindo Pharma Cambrex Dr. Reddy's Laboratories Actavis Wuxi Apptec Zhejiang NHU